• Home

• Small Molecules: Hit identification

• Small Molecules: Hit-to-Lead optimization

• Small Molecules: physicochemical properties

• Small Molecules: ADME

• Small Molecules: Toxicity

• Small Molecules: Selectivity

• Antibodies: Humanization and Optimization

• Protein Modeling. Discovery

• Protein Modeling: HERG binding

• Protein Modeling: Albumin binding

• Quantum Discussions Forum    

You access the old version of our website. Please point your browser to our new home page.

Quantum Pharmaceuticals’ R&D Program

Quantum Pharmaceuticals will develop drugs in all ten of these critical areas either in-house or through collaborations.

	Psychiatric Disorders		HIV/AIDS
	Obesity		Diabetes
	Rheumatoid Arthritis		Solid Organ Transplant
	Alzheimer’s disease		Atherosclerosis/Thrombosis
	Cancer		Hepatitis

Currently, our pipeline includes drug candidates for HIV/AIDS, Oncology, and Alzheimer's Disease.